ONCO/REVEAL - Trademark Details
Status: 700 - Registered
Serial Number
87619643
Registration Number
6389562
Word Mark
ONCO/REVEAL
Status
700 - Registered
Status Date
2021-06-15
Filing Date
2017-09-22
Registration Number
6389562
Registration Date
2021-06-15
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2018-03-20
Attorney Name
Law Office Assigned Location Code
N50
Employee Name
ALLEN, BIANCA LEIGH
Statements
Goods and Services
Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being in the fields of scientific research, clinical research, and scientific diagnostics research; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments for scientific research, clinical research, and scientific diagnostics research
Goods and Services
Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being for medical diagnostic purposes; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments, with the aforementioned reagents being used for medical diagnostic purposes; Biological and biochemical kits comprised of diagnostic preparations for medical purposes, namely, for the diagnosis and treatment of cancer
Goods and Services
Computer software for the collection, management, and analysis of data for use in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; computer software for analyzing biological samples; computer software for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; computer software for use with reagents and reagent kits, all for use in detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; computer software for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing
Goods and Services
Software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for collecting, managing, and analyzing data in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for analyzing biological samples; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others with reagents and reagent kits, all for use in detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; software as a service (Saas), namely, hosting non-downloadable computer software for use by others for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing; scientific research, namely, collection, management, and analysis of data in the fields of scientific research, clinical research and scientific diagnostics; providing biological sample testing services for others in the fields of scientific research, clinical research and scientific diagnostics; providing reagent sample testing and diagnostic services for others, namely, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, and scientific diagnostics research; genetic testing for scientific research purposes in the nature of providing bioinformatics and gene expression microarray image analysis services for others, namely, performing gene expression quantification, gene image processing, and gene information processing for others; medical diagnostic research, namely, collection, management, and analysis of data in the field of medical diagnostics
Goods and Services
Providing biological sample testing services for others in the field of medical diagnostics; providing biological sample testing services for others for medical purposes, namely, for the diagnosis and treatment of cancer; medical diagnostic testing in the nature of providing reagent sample testing and diagnostic services for others, namely, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the field of medical diagnostics
Pseudo Mark
ON CO/REVEAL
Classification Information
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2017-09-28
Primary Code
044
First Use Anywhere Date
2021-03-16
First Use In Commerce Date
2021-03-16
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Marcus Assefa
Address
Please log in with your Justia account to see this address.
Prior Registrations
| Relationship Type | Reel Number |
| Continuity Child | 87981050 |
| Continuity Child | 87982295 |
Madrid International Filings
Entry Number
1
Reference Number
A0097092
Original Filing Date USPTO
2020-05-29
International Registration Number
1555871
International Registration Date
2020-05-29
International Status Code
480
International Renewal Date
2030-05-29
| Madrid History Events | ||
| Date | Code | Description |
| 2020-06-20 | IRREQ | IRREGULARITY NOTICE RECEIVED FROM IB (RESPONSE REQUIRED) |
| 2020-10-15 | CREAT | APPLICATION FOR IR REGISTERED BY IB |
| 2020-08-28 | IRRCV | IRREGULARITY RESPONSE RECEIVED FROM APPLICANT |
| 2021-10-20 | CBPCP | PARTIAL CEASING OF EFFECT TO BE PROCESSED |
| 2020-08-12 | IRREQ | IRREGULARITY NOTICE RECEIVED FROM IB (RESPONSE REQUIRED) |
| 2022-01-04 | CBNAR | CEASING OF EFFECT REVIEWED - NO ACTION REQUIRED BY OFFICE |
| 2020-09-10 | IRSNT | IRREGULARITY RESPONSE SENT TO IB |
| 2020-06-02 | MCERT | MANUALLY CERTIFIED |
| 2020-06-02 | APPST | IR CERTIFIED AND SENT TO IB |
| 2020-09-03 | IRRAC | RESPONSE TO IRREGULARITY REVIEWED AND ACCEPTED |
| 2020-05-29 | NEWAP | NEW APPLICATION FOR IR RECEIVED |
| 2020-10-28 | CBPCP | PARTIAL CEASING OF EFFECT TO BE PROCESSED |
| 2020-07-21 | IRRCV | IRREGULARITY RESPONSE RECEIVED FROM APPLICANT |
| 2020-07-30 | IRRAC | RESPONSE TO IRREGULARITY REVIEWED AND ACCEPTED |
| 2020-07-30 | IRSNT | IRREGULARITY RESPONSE SENT TO IB |
| 2020-11-04 | CBNAR | CEASING OF EFFECT REVIEWED - NO ACTION REQUIRED BY OFFICE |
Trademark Events
| Event Date | Event Description |
| 2017-09-26 | NEW APPLICATION ENTERED IN TRAM |
| 2017-09-28 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2017-12-28 | ASSIGNED TO EXAMINER |
| 2018-01-04 | NON-FINAL ACTION WRITTEN |
| 2018-01-04 | NON-FINAL ACTION E-MAILED |
| 2018-01-04 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2018-01-24 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2018-01-24 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2018-01-25 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2018-02-08 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2018-02-28 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2018-03-20 | PUBLISHED FOR OPPOSITION |
| 2018-03-20 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2018-05-15 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2018-11-15 | TEAS EXTENSION RECEIVED |
| 2018-11-15 | EXTENSION 1 FILED |
| 2018-11-15 | EXTENSION 1 GRANTED |
| 2018-11-17 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2019-05-10 | TEAS EXTENSION RECEIVED |
| 2019-05-10 | TEAS REQUEST TO DIVIDE RECEIVED |
| 2019-05-29 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2019-05-10 | EXTENSION 2 FILED |
| 2019-05-29 | EXTENSION 2 GRANTED |
| 2019-05-10 | DIVISIONAL REQUEST RECEIVED |
| 2019-05-29 | DIVISIONAL PROCESSING COMPLETE |
| 2019-05-30 | CORRECTED NOA E-MAILED |
| 2019-05-30 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2019-11-11 | TEAS EXTENSION RECEIVED |
| 2019-11-11 | TEAS REQUEST TO DIVIDE RECEIVED |
| 2019-11-11 | EXTENSION 3 FILED |
| 2019-11-13 | EXTENSION 3 GRANTED |
| 2019-11-11 | DIVISIONAL REQUEST RECEIVED |
| 2019-11-13 | DIVISIONAL PROCESSING COMPLETE |
| 2019-11-14 | CORRECTED NOA E-MAILED |
| 2019-11-14 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2020-04-16 | TEAS EXTENSION RECEIVED |
| 2020-04-16 | EXTENSION 4 FILED |
| 2020-04-16 | EXTENSION 4 GRANTED |
| 2020-04-18 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2020-10-23 | TEAS EXTENSION RECEIVED |
| 2020-10-23 | EXTENSION 5 FILED |
| 2020-10-30 | EXTENSION 5 GRANTED |
| 2020-10-31 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2021-05-06 | TEAS STATEMENT OF USE RECEIVED |
| 2021-05-06 | USE AMENDMENT FILED |
| 2021-05-08 | STATEMENT OF USE PROCESSING COMPLETE |
| 2021-05-12 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 2021-05-13 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 2021-06-15 | REGISTERED-PRINCIPAL REGISTER |
